Silicon Valley Acquisition Corp. II
Filed PrimaryProposed symbol SVAT on Nasdaq Stock Market LLC · First filed Sep 21, 2026 · CIK 2145826
Effective prospectus: S-1 Sep 21, 2026 (0001213900-26-101822) · terms available
“Of the proceeds we receive from this offering and the sale of the private placement units, $220,000,000 or $253,000,000 if the underwriters' over-allotment option is exercised in full ($10.00 per unit), will be deposited into a segregated trust account located in the United States managed by Continental Stock Transfer & Trust Company”
What the company does
Silicon Valley Acquisition Corp. II is a Cayman Islands exempted company formed as a blank check special purpose acquisition company (SPAC). It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company intends to apply to list its units on Nasdaq under the symbol "SVAT" and has 24 months from the offering closing to consummate an initial business combination, after which it must redeem 100% of public shares or seek a shareholder-approved extension.
Use of proceeds
Of the proceeds from the offering and sale of the private placement units, $220,000,000 (or $253,000,000 if the over-allotment option is exercised in full) at $10.00 per unit will be deposited into a segregated trust account managed by Continental Stock Transfer & Trust Company. These funds will not be released to the company until the earlier of completion of an initial business combination, redemption of public shares in connection with certain charter amendments, or redemption of 100% of outstanding public shares if no business combination is completed within the 24-month completion window.
Underwriters
The completed effective-prospectus read stated no underwriters.
Extracted from S-1 0001213900-26-101822, filed Sep 21, 2026 and verified against that filing text.
Key risk factors
-
Founder shares dilution risk
“The nominal purchase price paid by our Sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our Sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.”
-
Conflicts of interest of management
“The price that our Sponsor, executive officers and directors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders.”
-
No Rule 419 protections
“Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.”
-
Listing approval risk
“We cannot guarantee that our securities will be approved for listing on Nasdaq.”
-
No current public market
“There is presently no public market for our units, Class A ordinary shares or warrants.”
-
Anti-dilution provisions risk
“The anti-dilution provisions in our Class B ordinary shares may result in issuance of additional shares to the holders of Class B ordinary shares and material dilution to the public shareholders' equity interests.”
-
Working capital loan dilution risk
“Up to $1,500,000 of such loans may be convertible into additional units of the post-business combination entity at a price of $10.00 per unit at the option of the lender, which could result in a material dilution to the public shareholders' equity interests.”
Financials before the first trade
The completed SEC companyfacts import produced no qualifying full-year financial history for this filer.
Filing history
| Filed | Form | Accession | |
|---|---|---|---|
| 2026-09-21 | S-1 | 0001213900-26-101822 | View on EDGAR |
Source quotes
Offer price: “Per Unit | $ | 10.00”